奥美医疗用品股份有限公司的主营业务是医用耗材及一次性医疗器械、感染防护用品、家庭护理产品的 研发、生产和销售。公司的主要产品是外科与伤口护理、感染防护、高级敷料、卫生护理。2020年11 月，公司"医用敷料智能工厂"项目入选2020年湖北省人工智能十大优秀应用案例（颁发单位：湖北省经 济和信息化厅）；2021年2月，公司获评"湖北省支柱产业细分领域隐形冠军科技小巨人（2020- 2022）"；2022年11月，奥美医疗名列"2022湖北民营企业制造业100强榜单"；2023年2月奥美医疗获 得"2022年度中国产学研合作创新成果优秀奖"；2023年11月，奥美医疗再度荣列工信部2022年中国医药 工业百强榜单，较上一次提升8名；2023年12月，奥美医疗"医用敷料智能制造示范工厂项目"获评工信 部"2023年度智能制造示范工厂"揭榜单位。2024年11月，奥美医疗再次荣登"2023－2024年度医药行业 信息统计（原中国医药行业最具影响力榜单）"榜单，获得"医疗器械营业收入前五十家企业"称号。 8月14日，奥美医疗今日收盘9.74元，下跌1.32%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到 ...

8月13日的资金流向数据方面，主力资金净流出687.86万元，占总成交额5.75%，游资资金净流入452.67 万元，占总成交额3.78%，散户资金净流入235.19万元，占总成交额1.96%。 证券之星消息，截至2025年8月13日收盘，奥美医疗(002950)报收于9.87元，下跌1.4%，换手率2.69%， 成交量12.15万手，成交额1.2亿元。 近5日资金流向一览见下表： | 指标 | 跑美医疗 | 医疗器械行业均值 | 行业排名 | | --- | --- | --- | --- | | 总市值 | 62.5亿元 | 120.64亿元 | 58 123 | | 净资产 | 35.26亿元 | 38.99亿元 | 43 123 | | 净利润 | 8650.27万元 | 7927.36万元 | 29 123 | | 市盈率(动) | 18.06 | 70.48 | 9 123 | | 市净率 | 1.8 | 4.02 | 28 123 | | 毛利率 | 30.52% | 51.34% | 104 123 | | 净利率 | 11.42% | 10.86% | 66 123 | | ROE | 2. ...

Core Insights - The report highlights the significant role of CFOs in listed companies, with the total compensation for A-share CFOs reaching 4.27 billion yuan in 2024, averaging 814,800 yuan per year [1][2] Group 1: CFO Compensation Overview - The average annual salary for CFOs in the A-share medical device sector is 908,600 yuan [2] - The distribution of CFO salaries shows that 24% earn below 500,000 yuan, 42% earn between 500,000 and 1 million yuan, 29% earn between 1 million and 2 million yuan, and 5% earn above 2 million yuan [2] - The top three highest-paid CFOs are Dai Zhenhua from Huatai Medical at 2.70 million yuan, Rui Chenwei from Nanwei Medical at 2.65 million yuan, and Wu Jinhong from Guoke Hengtai at 1.77 million yuan [2] Group 2: CFO Demographics - The age distribution of CFOs shows that those aged 40-50 make up 57%, while 32% are over 50, and 11% are 40 or younger [1] - The youngest CFO is 31 years old, while the oldest is 60 years old [1] - In terms of educational background, 16% of CFOs have an associate degree, 66% hold a bachelor's degree, 16% have a master's degree, and only 2% possess a doctoral degree [1] Group 3: Salary Changes - Among CFOs with over two years of tenure, the largest salary decrease was observed for Kong Xiangqian from Aidi Te, with a decline of 16.86% year-on-year [2] - Conversely, the largest salary increase was for Song Yizhao from Shandong Glass, with a rise of 144.86% year-on-year [2]

截至2025年8月1日收盘，奥美医疗(002950)报收于9.36元，上涨1.08%，换手率1.25%，成交量5.65万 手，成交额5282.44万元。 当日关注点 交易信息汇总 8月1日，奥美医疗的资金流向如下：主力资金净流入544.14万元；游资资金净流出336.92万元；散户资 金净流出207.22万元。 股本股东变化 公司公告汇总关于持股5%以上股东权益变动暨披露简式权益变动报告书的提示性公告 奥美医疗用品股份有限公司发布公告，陈浩华先生于2025年7月22日至7月30日通过大宗交易形式减持 7482900股公司A股股票，减持后其持有61353421股公司A股股票，持股比例变动触及5%的整数倍。本 次权益变动不涉及控股股东及一致行动人增持或减持，不会导致公司控股股东及实际控制人发生变化。 关于股份回购进展的公告 奥美医疗用品股份有限公司董事会审议通过了以集中竞价交易方式回购公司股份的议案，用于股权激励 或员工持股计划。截至2025年7月31日，公司累计回购股份1,987,400股，占总股本的0.3138%，支付总 金额为18,001,207.00元。回购价格不超过11.00元/股，资金总额不低于5,0 ...

Core Viewpoint - The company, Aomei Medical Supplies Co., Ltd., has initiated a share repurchase plan to enhance shareholder value and support employee stock ownership programs, with a total repurchase budget between RMB 50 million and RMB 100 million [2][3]. Share Repurchase Progress - As of July 31, 2025, the company has repurchased a total of 1,987,400 shares, representing 0.3138% of the total share capital, with a total expenditure of RMB 18,001,207, excluding transaction costs [3][4]. - The highest and lowest prices for the repurchased shares were RMB 9.26 and RMB 8.33 per share, respectively [3]. Shareholder Equity Change - Major shareholder Chen Haohua reduced his holdings by 7,482,900 shares through block trading from July 22 to July 30, 2025, bringing his total holdings to 61,353,421 shares [10][11]. - This reduction in shareholding does not affect the control structure of the company and complies with the previously announced reduction plan [9][11].

Summary of Key Points Core Viewpoint - The announcement details a significant reduction in shareholding by a major shareholder, Chen Haohua, of Aomei Medical Supplies Co., Ltd, through block trading, which does not affect the company's control structure or ongoing operations [1][2]. Group 1: Shareholding Changes - Chen Haohua reduced his shareholding from 68,836,321 shares (11.12%) to 61,353,421 shares (9.92%) [1]. - The reduction in shareholding touches a 5% integer multiple, indicating a notable change in ownership percentage [1]. Group 2: Compliance and Governance - The company assures that the reduction in shareholding will not lead to changes in the controlling shareholder or actual controller, nor will it impact the company's governance structure and sustainability [2]. - The announcement complies with the relevant disclosure regulations as per the guidelines for public securities [1].

Core Viewpoint - The report details a shareholding reduction by Chen Haohua, a significant shareholder of Aomei Medical Supplies Co., Ltd., due to personal financial needs, resulting in a decrease in his shareholding from 68,836,321 shares (11.12%) to 61,353,421 shares (9.92%) [4][5]. Group 1: Shareholding Changes - The shareholder reduced his stake by 7,482,900 shares through block trading at an average price of 8.47 RMB per share, representing a reduction of 1.21% of the total share capital [4][5]. - Prior to the reduction, the shareholder held 68,836,321 shares, which accounted for 11.12% of the total share capital [4][5]. - Following the reduction, the shareholder's stake fell below 10% of the total share capital [4]. Group 2: Regulatory Compliance - The report was prepared in accordance with the Company Law, Securities Law, and relevant regulations, ensuring that all necessary authorizations and approvals were obtained [1][2]. - The shareholder confirmed that the report does not contain any false records, misleading statements, or significant omissions, and he bears legal responsibility for its accuracy [2][3]. Group 3: Future Plans - The shareholder does not rule out the possibility of further increasing or decreasing his shareholding in the next 12 months, and any future changes will be disclosed in accordance with legal requirements [4][6]. - The shareholder had previously reduced his holdings by 4,214,000 shares on July 21, 2025, indicating a pattern of share reduction [5][6].

Group 1 - The company, Aomei Medical (002950.SZ), announced a share buyback program, having repurchased a total of 1.9874 million shares as of July 31, 2025, which represents 0.3138% of its total share capital [1] - The highest transaction price during the buyback was 9.26 yuan per share, while the lowest was 8.33 yuan per share [1] - The total amount spent on the share buyback was 18.0012 million yuan, excluding transaction fees such as stamp duty and commissions [1]

证券代码：002950 证券简称：奥美医疗 公告编号：2025-041 奥美医疗用品股份有限公司 关于股份回购进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 奥美医疗用品股份有限公司（以下简称"公司"）董事会于 2025 年 1 月 20 日召开第 三届董事会第十二次会议，审议通过了《关于以集中竞价交易方式回购公司股份方案的议 案》，同意公司以自有资金及股票回购专项贷款资金通过集中竞价交易方式回购公司股份， 用于股权激励或员工持股计划。本次回购价格不超过人民币 11.00 元/股（含），回购股份 的资金总额不低于人民币 5,000 万元（含）且不超过人民币 10,000 万元（含），具体回购 资金总额以实际使用的资金总额为准。回购股份的实施期限为自公司董事会审议通过本次 回购方案之日起 12 个月内。具体内容详见公司分别于 2025 年 1 月 22 日、2025 年 1 月 24 日披露于巨潮资讯网（www.cninfo.com.cn）等指定信息披露媒体的《关于回购公司股 份方案暨取得股票回购专项贷款的公告》（公告编号：2025-001）和《关于 ...

奥美医疗用品股份有限公司 信息披露义务人：陈浩华 住所及通讯地址：广东省深圳市南山区龙珠四路 X 号 股份变动性质：减持 签署日期：2025 年 8 月 1 日 简式权益变动报告书 信息披露义务人声明 上市公司名称：奥美医疗用品股份有限公司 股票上市地点：深圳证券交易所 股票简称：奥美医疗 股票代码：002950 截止本报告书签署之日，除本报告书披露的信息外，信息披露义务人没有通过任何 其他方式增加或减少其在奥美医疗拥有权益的股份； 四、本次权益变动是根据本报告所载明的资料进行的。除本信息披露义务人外，没 有委托或者授权任何其他人提供未在本报告书中列载的信息和对本报告书做出任何解 释或者说明； 五、信息披露义务人承诺本报告不存在虚假记载、误导性陈述或重大遗漏，并对其 真实性、准确性、完整性承担个别和连带的法律责任。 | 第一节 | 信息披露义务人介绍 5 | | --- | --- | | 第二节 | 权益变动的目的及计划 6 | | 第三节 | 权益变动方式 7 | | 第四节 | 权益变动前 6 个月内买卖上市公司股份的情况 9 | | 第五节 | 其他重大事项 10 | | 第六节 | 备查文件 11 ...